| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $21.0M | $2.0M | $0 |
| YoY Revenue Growth % | +929.4% | — | — |
| Gross Profit | $11.3M | $1.3M | — |
| Gross Margin % | 53.8% | 63.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$82.6M | -$109.2M | -$78.2M |
| Operating Margin % | -80.0% | -80.0% | — |
| Net Income (GAAP) | -$72.5M | -$100.2M | -$53.4M |
| EBITDA (Normalized) | -$80.3M | -$99.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$58.4M | -$66.1M | -$56.4M |
| Capital Expenditures (CapEx) | $2.9M | $12.2M | — |
| Free Cash Flow (FCF) | -$61.2M | -$78.3M | -$56.4M |
| FCF Margin % | -80.0% | -80.0% | — |
| Return on Invested Capital (ROIC %) | -35.2% | -45.0% | — |
| Cash & Short-Term Equivalents | $29.5M | $128.8M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $214.8M | $278.3M | — |